Qube Research & Technologies (QRT)’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-67,230
Closed -$1.22M 3625
2024
Q3
$1.22M Buy
+67,230
New +$1.56M ﹤0.01% 1959
2023
Q3
Sell
-91,589
Closed -$3.77M 4194
2023
Q2
$3.77M Buy
91,589
+36,861
+67% +$1.77M 0.01% 789
2023
Q1
$3.14M Sell
54,728
-21,996
-29% -$1.24M 0.01% 814
2022
Q4
$4.3M Sell
76,724
-139,510
-65% -$7.1M 0.02% 712
2022
Q3
$9.16M Buy
216,234
+113,129
+110% +$5.8M 0.05% 434
2022
Q2
$5.57M Sell
103,105
-81,998
-44% -$4.92M 0.04% 469
2022
Q1
$11.9M Buy
185,103
+115,670
+167% +$7.62M 0.1% 254
2021
Q4
$4.65M Buy
+69,433
New +$4.7M 0.04% 581
2021
Q3
Sell
-9,601
Closed -$655K 2451
2021
Q2
$655K Buy
+9,601
New +$679K 0.01% 1144
2020
Q3
Sell
-65,130
Closed -$3.06M 1869
2020
Q2
$3.06M Buy
+65,130
New +$3.2M 0.04% 511
2020
Q1
Sell
-27,689
Closed -$1.61M 1378
2019
Q4
$1.61M Buy
+27,689
New +$1.65M 0.05% 435
2018
Q4
Sell
-2,499
Closed -$165K 565
2018
Q3
$165K Buy
2,499
+1,635
+189% +$102K 0.02% 570
2018
Q2
$56K Buy
+864
New +$53.5K 0.04% 477

Other funds holding IART

Qube Research & Technologies (QRT)'s IART Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Integra LifeSciences (IART) in Q4 2024, closing a stake of 67,230 shares — an estimated $1.22M sold.

Qube Research & Technologies (QRT) first reported a position in IART in Q2 2018 and held it in 13 quarters. The position peaked at $11.9M in Q1 2022. 223 funds tracked by Wall St. Rank hold IART as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Integra LifeSciences position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 67,230 Integra LifeSciences shares in Q4 2024, an estimated $1.22M.
  • Qube Research & Technologies (QRT) first reported a position in Integra LifeSciences in Q2 2018 and held it in 13 quarters.
  • Qube Research & Technologies (QRT)'s Integra LifeSciences position peaked at $11.9M in Q1 2022.
  • 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.